GSI 7916 (Epclusa sofosbuvir 400 mg / velpatasvir 100 mg)
Generic Name: sofosbuvir/velpatasvir
This pill with imprint "GSI 7916" is Pink, Four-sided and has been identified as Epclusa sofosbuvir 400 mg / velpatasvir 100 mg. It is manufactured by Gilead Sciences, Inc..
Epclusa is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Epclusa sofosbuvir 400 mg / velpatasvir 100 mg is classified as a Schedule U controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- sofosbuvir/velpatasvir
- Imprint:
- GSI 7916
- Strength:
- sofosbuvir 400 mg / velpatasvir 100 mg
- Color:
- Pink
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Antiviral combinations
- CSA Schedule:
- U - Unknown
- Manufacturer:
- Gilead Sciences, Inc.
More about Epclusa (sofosbuvir / velpatasvir)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 47 Reviews – Add your own review/rating
- Drug class: antiviral combinations
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
